Earnings call transcript: BrasilAgro reports Q3 2026 loss amid revenue decline

BrasilAgro reported a BRL 76 million net loss for the first nine months of 2026, versus BRL 76 million profit a year earlier, as revenue fell 27% to BRL 637 million and adjusted EBITDA dropped 78% to BRL 42.8 million. Management blamed weaker sugarcane and cotton prices, higher input costs tied to geopolitics and natural gas, and El Niño risk, while noting a strong BRL 887 million cash position and continued dividend payments. Shares rose 1.56% premarket, suggesting investors were focused on liquidity and recovery potential rather than near-term earnings weakness.

Analysis

The core takeaway is not the headline loss; it is the mismatch between operating leverage and balance-sheet resilience. This is a land-and-crop platform with enough liquidity to survive a bad pricing cycle, but not enough earnings power to ignore a second consecutive year of elevated input costs and weak realized prices. That combination argues for a lower-quality, more volatile recovery path than the market seems to be pricing in.

The second-order winner from this setup is not BrasilAgro itself, but upstream input suppliers and logistics counterparties that can reprice into a constrained planting season. Management is effectively signaling that nitrogen exposure is the real margin swing factor over the next 1-2 quarters, while phosphate/potash risk is more about timing than outright volume destruction. If weather delays planting and fertilizer is pushed into a tighter window, working-capital intensity rises just as the company is trying to de-lever off receivables.

The market may be underestimating how much of the apparent protection comes from hedging and asset sales rather than structural earnings improvement. Those are useful shock absorbers, but they do not fix the underlying sensitivity to commodity/FX whipsaw or the growing probability that weather forces suboptimal acreage decisions over the next planting cycle. The most important catalyst is the next planting budget: if the company trims area or input intensity more than expected, the stock can rerate down even if near-term cash remains intact.

Contrarianly, the stock is not obviously cheap because the business is moving from an earnings story to a balance-sheet and execution story. In that regime, fair-value screens are less relevant than the trajectory of farm receivables, realized margins, and the degree to which weather forces management to trade volume for risk control. For now, the asymmetry looks better in selling rally attempts than in chasing a recovery.

Key Decisions for Investors

• Short LND on strength over the next 2-6 weeks; use the post-earnings relief bid to fade a move back toward fair value, with a stop if commodity prices or BRL weaken materially. Risk/reward: limited upside if execution stabilizes, but meaningful downside if planting decisions get more conservative.
• Pair trade: long fertilizer/input beneficiaries vs. short LND for the next planting cycle window. Best expressed through UAN or CF on any dip versus LND; thesis is that BrasilAgro is forced to absorb higher agronomic costs while suppliers reprice scarcity.
• Sell LND upside via call spreads if liquid options are available, 1-3 month tenor. The earnings profile is too noisy for a clean long, but a capped structure monetizes the elevated volatility and the likelihood that near-term catalysts are more negative than positive.
• If you need exposure to the thematic, prefer a basket of Brazil ag/land names with stronger balance sheets over LND. The risk/reward favors operators with less reliance on hedging and asset monetization to bridge the cycle.
• Watch for a 1-2 quarter inflection in receivables and acreage guidance; if management confirms delayed planting or lower nitrogen application rates, add to the short. That would signal the cyclical trough is lasting longer than consensus expects.